Biovica International
15.9.2021 08:21:46 CEST | ACCESS Newswire | Press release
UPPSALA, SE / ACCESSWIRE / September 15, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)
Biovica, active in cancer diagnostics, today announces that DiviTum®TKa results from an analysis of samples from the large SWOG S0226 study have been published in the highly ranked peer-reviewed scientific journal Clinical Cancer Research, published by the American Association for Cancer Research (AACR). The strong results support using DiviTum®TKa as a tool to monitor disease progression with endocrine therapy in women with hormone receptor positive metastatic breast cancer.
"SWOG researchers have demonstrated that a blood serum test can identify which of these patients have slow-growing disease that might be controlled with a simple aromatase inhibitor pill alone," said co-author of the paper, Dr. Lajos Pusztai, MD, PhD, Yale University Cancer Center.
"We are very proud to see the strong DiviTum®TKa results being published in Clinical Cancer Research. This highly reputable scientific journal by AACR focuses on innovative clinical and translational research bridging the laboratory and the clinic. The publication is a great recognition for DiviTumTKa and an important step to establishing the test as a standard tool for monitoring treatment of metastatic breast cancer to the benefit of patients and payers," said Anders Rylander, CEO of Biovica.
As previously announced, results demonstrate that patients with low TKa levels (using a predefined cut-off) before treatment initiation will do significantly better than patients expressing high levels of TKa. Progression free survival (PFS) was 17.3 vs 11.2 months and overall survival (OS) was 58 vs 30 months, respectively. In addition, similar results were observed during treatment, where patients with low TKa showed significantly longer PFS and OS. Furthermore, results support the potential clinical use of DiviTum®TKa to identify low-TKa patients as best suited for endocrine monotherapy, whereas those with elevated TKa values appear to benefit from combination therapies.
The analysis measured thymidine kinase activity (TKa) levels in 1,726 serum samples from more than 400 patients in SWOG S0226 and is the largest study to evaluate DiviTum®TKa for prognostic and serial monitoring of metastatic breast cancer. The study constitutes the foundation for the clinical validation of DiviTum®TKa in Biovica's 510(k)-application to the FDA. DiviTum®TKa is 510(k) pending. Not available for sale in the United States.
Link to study: Clinical Cancer Research
Contact
Anders Rylander, CEO
Phone: +46-18-444 48 35
E-mail: anders.rylander@biovica.com
Biovica - Treatment decisions with greater confidence
Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments. Biovica's assay DiviTum® measure cell proliferation by detecting a biomarker in the blood stream. The assay has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. The first application for DiviTum is monitoring of treatment for patients with metastatic breast cancer. Biovica's vision is that all cancer patients will get an optimal treatment from day one. Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum is CE-marked and registered with the Swedish Medical Products Agency. Biovica's shares are traded on the Nasdaq First North Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser, info@fnca.se , +46 8 528 00 399. For more information please visit: www.biovica.com .
SOURCE: Biovica International
View source version on accesswire.com:
https://www.accesswire.com/664165/DiviTumRTKa-Results-from-SWOG-Study-Published-in-Clinical-Cancer-Research
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform1.4.2026 17:50:00 CEST | Press release
DVLT × Demora Foundation: Datavault AI's Enterprise AI Stack Deployed as the Data Intelligence & RWA Tokenization Layer for K-Pop, K-Drama, K-Entertainment, and K-Culture IP - Serving 200M+ Hallyu Fans Across 156 Countries Through K2Global's 500+ Korean SMB Network and Three US Innovation K-Wave Cities PHILADELPHIA, PA AND WILMINGTON, DE / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institution
Stagwell Announces UNICEPTA UK and Hootsuite Strategic Partnership to Deliver Decision-Grade Media Intelligence Within the Talkwalker Platform1.4.2026 17:00:00 CEST | Press release
Bringing together advanced technology and social insights to provide enterprise-ready, decision-grade media intelligence. LONDON, GB / ACCESS Newswire / April 1, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced a strategic partnership between UNICEPTA, Stagwell's global provider of human-led, AI-fed media intelligence, and Hootsuite for their UK business. The collaboration integrates UNICEPTA UK's specialist media intelligence services into Hootsuite's Talkwalker platform environment, strengthening the intelligence capabilities available to communications leaders operating in complex, high-stakes environments. "Many FTSE 100 organisations already trust the combined UNICEPTA and Talkwalker solution. Our partnership with Hootsuite builds on that foundation - bringing together enterprise-level social intelligence with UNICEPTA's global content platform and managed services to deliver faster, more consistent and more actionable
Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers1.4.2026 15:00:00 CEST | Press release
Multi-year partnership introduces verified environmental reporting and new fan-driven climate action across Little Caesars Arena and Comerica Park. CALGARY, AB / ACCESS Newswire / April 1, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or "the Company") today announced a multi-year sustainability partnership with the Detroit Red Wings and Detroit Tigers, establishing Karbon-X as the Official Sustainability Partner across both teams through Ilitch Sports + Entertainment. The collaboration brings verified climate action to two of Detroit's most celebrated franchises, supporting long-term environmental strategy at Little Caesars Arena and Comerica Park, and introducing new ways for fans to participate in meaningful sustainability efforts. As part of the partnership, Karbon-X will deliver independent, third-party greenhouse gas reporting for both organizations. These insights will support future planning and help identify opportunities to strengthen environmental performance across venue o
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago1.4.2026 14:00:00 CEST | Press release
Private Round Table Follows Tech Summit Appearance in Utah for International Lawyers, Addressing Advancements in AI PHILADELPHIA, PA / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT) CEO Nate Bradley will present at a private investor round table on Thursday, April 02, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation to the venue in two months following a strong institutional reception in February. The invitation follows presentations Bradley delivered earlier this week to leading global attorneys on AI applications in legal practice and data governance. The return engagement comes amid growing institutional interest in Datavault AI's approach to data monetization, verified credentialing, and real-world asset tokenization. It reflects growing market recognition of Datavault AI's differentiated position at the intersection of data ownership, tokenization, and AI-enabled revenue generation. The April round table builds on momentum from
Jenny Hammarberg Appointed CEO of Lawline - Bringing Legal Expertise to Users Through AI1.4.2026 13:15:00 CEST | Press release
Lawline has appointed Jenny Hammarberg as its new Chief Executive Officer. She joins from her previous role as CEO of Setterwalls Advokatbyrå in Gothenburg and has previous experience as a management consultant at EY. She takes on the role at a pivotal moment as Lawline launches its new platform for businesses, organisations, and private individuals. STOCKHOLM, SE / ACCESS Newswire / April 1, 2026 / Lawline, the market leader for accessible law online since 2005, has set its sights on transforming how legal services are accessed and used. Rather than legal advice being purchased reactively after the fact, the vision is for legal guidance to be available at the moment of decision. "I have seen too many situations where legal counsel arrives when it is already too late - where a simple answer could have saved money, unnecessary frustration, and energy. Legal support should not be something you activate when things are already on fire." - Jenny Hammarberg, CEO, Lawline Lawline is position
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom